These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 21386016

  • 1. Extended-spectrum beta-lactamase-producing bacterial infections in adult solid organ transplant recipients.
    Winters HA, Parbhoo RK, Schafer JJ, Goff DA.
    Ann Pharmacother; 2011 Mar; 45(3):309-16. PubMed ID: 21386016
    [Abstract] [Full Text] [Related]

  • 2. Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy.
    Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, Oh MD, Choe KW.
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4574-81. PubMed ID: 15561828
    [Abstract] [Full Text] [Related]

  • 3. Prevalence of multidrug-resistant gram-negative bacilli producing extended-spectrum β-lactamases (ESBLs) and ESBL genes in solid organ transplant recipients.
    Men TY, Wang JN, Li H, Gu Y, Xing TH, Peng ZH, Zhong L.
    Transpl Infect Dis; 2013 Feb; 15(1):14-21. PubMed ID: 23013385
    [Abstract] [Full Text] [Related]

  • 4. Clinical outcomes with ertapenem as a first-line treatment option of infections caused by extended-spectrum β-lactamase producing gram-negative bacteria.
    Fong JJ, Rosé L, Radigan EA.
    Ann Pharmacother; 2012 Mar; 46(3):347-52. PubMed ID: 22395250
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of risk factors for the acquisition of bloodstream infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in the intensive care unit; antibiotic management and clinical outcome.
    Cordery RJ, Roberts CH, Cooper SJ, Bellinghan G, Shetty N.
    J Hosp Infect; 2008 Feb; 68(2):108-15. PubMed ID: 18063198
    [Abstract] [Full Text] [Related]

  • 6. Bacteremia due to extended-spectrum beta-lactamase-producing Enterobacteriaceae other than Escherichia coli and Klebsiella.
    Huang SS, Lee MH, Leu HS.
    J Microbiol Immunol Infect; 2006 Dec; 39(6):496-502. PubMed ID: 17164953
    [Abstract] [Full Text] [Related]

  • 7. Prior use of carbapenems may be a significant risk factor for extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella spp. in patients with bacteraemia.
    Martínez JA, Aguilar J, Almela M, Marco F, Soriano A, López F, Balasso V, Pozo L, Mensa J.
    J Antimicrob Chemother; 2006 Nov; 58(5):1082-5. PubMed ID: 16950822
    [Abstract] [Full Text] [Related]

  • 8. Infections due to Escherichia coli producing extended-spectrum beta-lactamase among hospitalised patients: factors influencing mortality.
    Peña C, Gudiol C, Calatayud L, Tubau F, Domínguez MA, Pujol M, Ariza J, Gudiol F.
    J Hosp Infect; 2008 Feb; 68(2):116-22. PubMed ID: 18226420
    [Abstract] [Full Text] [Related]

  • 9. Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing enterobacteriaceae: variability by site of infection.
    Hyle EP, Lipworth AD, Zaoutis TE, Nachamkin I, Bilker WB, Lautenbach E.
    Arch Intern Med; 2005 Jun 27; 165(12):1375-80. PubMed ID: 15983286
    [Abstract] [Full Text] [Related]

  • 10. Urinary tract infection caused by extended-spectrum beta-lactamase-producing bacteria in kidney transplant patients.
    Pinheiro HS, Mituiassu AM, Carminatti M, Braga AM, Bastos MG.
    Transplant Proc; 2010 Mar 27; 42(2):486-7. PubMed ID: 20304172
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinical features of nosocomial infections by extended-spectrum beta-lactamase-producing Enterobacteriaceae in neonatal intensive care units.
    Chiu S, Huang YC, Lien RI, Chou YH, Lin TY.
    Acta Paediatr; 2005 Nov 27; 94(11):1644-9. PubMed ID: 16303704
    [Abstract] [Full Text] [Related]

  • 13. Risk factors and outcome of extended-spectrum β-lactamase-producing Enterobacter cloacae bloodstream infections.
    Qureshi ZA, Paterson DL, Pakstis DL, Adams-Haduch JM, Sandkovsky G, Sordillo E, Polsky B, Peleg AY, Bhussar MK, Doi Y.
    Int J Antimicrob Agents; 2011 Jan 27; 37(1):26-32. PubMed ID: 21075605
    [Abstract] [Full Text] [Related]

  • 14. Risk factors associated with preoperative fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in liver transplant recipients.
    Bert F, Larroque B, Dondero F, Durand F, Paugam-Burtz C, Belghiti J, Moreau R, Nicolas-Chanoine MH.
    Transpl Infect Dis; 2014 Feb 27; 16(1):84-9. PubMed ID: 24330161
    [Abstract] [Full Text] [Related]

  • 15. Clinical implications of extended spectrum beta-lactamase (ESBL) producing Klebsiella species and Escherichia coli on cefepime effectiveness.
    Kotapati S, Kuti JL, Nightingale CH, Nicolau DP.
    J Infect; 2005 Oct 27; 51(3):211-7. PubMed ID: 16230218
    [Abstract] [Full Text] [Related]

  • 16. Outcomes evaluation of patients with ESBL- and non-ESBL-producing Escherichia coli and Klebsiella species as defined by CLSI reference methods: report from the SENTRY Antimicrobial Surveillance Program.
    Bhavnani SM, Ambrose PG, Craig WA, Dudley MN, Jones RN, SENTRY Antimicrobial Surveillance Program.
    Diagn Microbiol Infect Dis; 2006 Mar 27; 54(3):231-6. PubMed ID: 16423491
    [Abstract] [Full Text] [Related]

  • 17. Infection with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in solid organ transplantation.
    Bergamasco MD, Barroso Barbosa M, de Oliveira Garcia D, Cipullo R, Moreira JC, Baia C, Barbosa V, Abboud CS.
    Transpl Infect Dis; 2012 Apr 27; 14(2):198-205. PubMed ID: 22093103
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of ertapenem for consolidation therapy of extended-spectrum beta-lactamase-producing gram-negative infections: a case series report.
    Berg ML, Crank CW, Philbrick AH, Hayden MK.
    Ann Pharmacother; 2008 Feb 27; 42(2):207-12. PubMed ID: 18230703
    [Abstract] [Full Text] [Related]

  • 19. Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum β-lactamase bacteremia.
    Tamma PD, Han JH, Rock C, Harris AD, Lautenbach E, Hsu AJ, Avdic E, Cosgrove SE, Antibacterial Resistance Leadership Group.
    Clin Infect Dis; 2015 May 01; 60(9):1319-25. PubMed ID: 25586681
    [Abstract] [Full Text] [Related]

  • 20. Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy.
    Lee J, Pai H, Kim YK, Kim NH, Eun BW, Kang HJ, Park KH, Choi EH, Shin HY, Kim EC, Lee HJ, Ahn HS.
    J Antimicrob Chemother; 2007 Sep 01; 60(3):629-37. PubMed ID: 17599919
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.